Please login to the form below

Not currently logged in
Email:
Password:

Indoco and Watson Pharma in deal

Indian company Indoco Remedies has signed a deal with US-based Watson Pharmaceuticals to develop generic products for the US market

Indoco Remedies has signed a deal with US-based Watson Pharmaceuticals to develop generic products for the US market.

Shares of the Mumbai-based Indoco surged 4.95 per cent on the Bombay Stock Exchange after the announcement.

Under this deal, Indoco will develop, manufacture and supply a number of products that currently have yearly sales of $679m.

Indoco's chairman and managing director Suresh G Kare has said it is a remarkable achievement to be out-licensing technology to a company of Watson's scale.

2nd February 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
ROAD

ROAD is a digital PR and communications consultancy specialising in promoting the innovators that shape our future health and wellbeing....

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...